191
Participants
Start Date
March 31, 2012
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
SAR292833
"Pharmaceutical form: capsule~Route of administration: oral"
placebo
"Pharmaceutical form:capsule~Route of administration: oral"
Investigational Site Number 348001, Budapest
Investigational Site Number 348005, Budapest
Investigational Site Number 348007, Budapest
Investigational Site Number 348002, Budapest
Investigational Site Number 804005, Kiev
Investigational Site Number 348006, Debrecen
Investigational Site Number 348003, Zalaegerszeg
Investigational Site Number 840001, New York
Investigational Site Number 203005, Prague
Investigational Site Number 203006, Prague
Investigational Site Number 840040, Hartsdale
Investigational Site Number 840033, Rochester
Investigational Site Number 840044, Altoona
Investigational Site Number 840018, Johnstown
Investigational Site Number 840022, Winston-Salem
Investigational Site Number 840015, Raleigh
Investigational Site Number 840046, Coral Gables
Investigational Site Number 840034, Palm Beach Gardens
Investigational Site Number 840013, Ocala
Investigational Site Number 840045, Tullahoma
Investigational Site Number 840017, Toledo
Investigational Site Number 840012, Indianapolis
Investigational Site Number 840019, Evansville
Investigational Site Number 840035, St Louis
Investigational Site Number 840043, Dallas
Investigational Site Number 840032, Dallas
Investigational Site Number 203002, Olomouc
Investigational Site Number 840006, Austin
Investigational Site Number 840037, Albuquerque
Investigational Site Number 840010, Las Vegas
Investigational Site Number 840020, Newport Beach
Investigational Site Number 840038, Santa Ana
Investigational Site Number 840002, Tustin
Investigational Site Number 840007, Garden Grove
Investigational Site Number 703004, Banská Bystrica
Investigational Site Number 840016, Seattle
Investigational Site Number 643008, Moscow
Investigational Site Number 643010, Moscow
Investigational Site Number 643009, Moscow
Investigational Site Number 643001, Moscow
Investigational Site Number 643005, Yaroslavl
Investigational Site Number 643013, Saint Petersburg
Investigational Site Number 643003, Saint Petersburg
Investigational Site Number 643014, Saint Petersburg
Investigational Site Number 643006, Kazan'
Investigational Site Number 643007, Kazan'
Investigational Site Number 643004, Nizhny Novgorod
Investigational Site Number 643012, Novosibirsk
Investigational Site Number 840014, Tucson
Investigational Site Number 840042, Framingham
Investigational Site Number 840004, Springfield
Investigational Site Number 616001, Bydgoszcz
Investigational Site Number 616002, Lublin
Investigational Site Number 616007, Sandomierz
Investigational Site Number 616004, Włocławek
Investigational Site Number 643011, Moscow
Investigational Site Number 804003, Kyiv
Investigational Site Number 703001, Dubnica nad Váhom
Investigational Site Number 703003, Krompachy
Investigational Site Number 804002, Kiev
Investigational Site Number 804004, Kyiv
Lead Sponsor
Sanofi
INDUSTRY